A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders. Detection of latency-associated Epstein-Barr virus transcripts in the crusts

Journal of Microbiological Methods

Volumn 68, Issue 2, 2007, Pages 403-407

  Yamamoto, Takenobu ^a   Tsuji, Kazuhide ^a   Suzuki, Daisuke ^a   Morizane, Shin ^a   Iwatsuki, Keiji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Crust; EB virus; EBER; Hydroa vacciniforme; Noninvasive

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; MESSENGER RNA; SMALL NUCLEAR RNA; VIRUS RNA;

AMPLICON; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA SEQUENCE; EPSTEIN BARR VIRUS; FEMALE; GENE AMPLIFICATION; HUMAN; HYDROA VACCINIFORME; HYPERSENSITIVITY; INSECT BITE; MALE; MOLECULAR PROBE; MOSQUITO; NATURAL KILLER T CELL; NON INVASIVE MEASUREMENT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SKIN LYMPHOMA; T CELL LYMPHOMA; TRANSCRIPTOMICS; VIRAL SKIN DISEASE; VIRUS DETECTION; VIRUS TRANSCRIPTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; HYDROA VACCINIFORME; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 33846456610     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2006.09.025     Document Type: Article

References (11)

1. Asada H., Miyagawa S., Sumikawa Y., Yamaguchi Y., Itami S., Suguri S., Harada M., Tokura Y., Ishihara S., Ohshima S., and Yoshikawa K. CD4+T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. Arch. Dermatol. 139 (2003) 1601-1607
2. Brooks L.A., Lear A.L., Young L.S., and Rickinson A.B. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J. Virol. 67 (1993) 3182-3190
3. Cohen J.I. Epstein-Barr virus infection. New Engl. J. Med. 343 (2000) 481-492
4. Iwatsuki K., Xu Z., Takata M., Iguchi M., Ohtsuka M., Akiba H., Mitsuhashi Y., Takenoshita H., Sugiuchi R., Tagami H., and Kaneko F. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br. J. Dermatol. 140 (1999) 715-721
5. Iwatsuki K., Satoh M., Yamamoto T., Oono T., Morizane S., Ohtsuka M., Xu Z.G., Suzuki D., and Tsuji K. Pathogenic Link Between hydroa vacciniforme and Epstein-Barr virus-associated hematological disorders. Arch. Dermatol. 142 (2006) 587-595
6. Kimura H., Morita M., Yabuta Y., Kuzushima K., Kato K., Kojima S., Matsuyama T., and Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 37 (1999) 132-136
7. Lupberger J., Kreuzer K.A., Baskaynak G., Peters U.R., le Coutre P., and Schmidt C.A. Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol. Cell. Probes 16 (2002) 25-30
8. Nitta Y., Iwatsuki K., Kimura H., Kojima S., Morishima T., Tsuji K., and Oono T. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders. Eur. J. Dermatol. 15 (2005) 503-506
9. Tierney R.J., Steven N., Young L.S., and Rickinson A.B. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68 (1994) 7374-7385
10. Tokura Y., Ishihara S., Tagawa S., Seo N., Ohshima K., and Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J. Am. Acad. Dermatol. 45 (2001) 569-578
11. Yamamoto T., Fujii K., Tsuji K., Akazai A., Oda M., Imai S., and Iwatsuki K. Characterization of Epstein-Barr virus-infected natural killer lymphocytes in a patient with hypersensitivity to mosquito bites. J. Am. Acad. Dermatol. 53 (2005) 912-914